You have not said anything yet. You have noticed the afternoons when the person you share a life with goes quiet. You have noticed the cholesterol number from their last physical that came with a "let's keep an eye on it," and the belt that moved a notch two winters ago. So you have started reading at night once the children are asleep. Somewhere in that reading you typed a phrase close to "health membership for my partner," landed on a wall of weight-loss medication ads, and closed the tab. The one conversation you do not want to start is the one that sounds like a comment on their body.
The question under that search is the one this piece answers: is a GoodLife Health membership only for weight loss? No. Weight is one of several things the clinician measures and, where indicated, treats. The clearest way to show that is to walk through the first three months. The patient in that walk-through, whom we will call Alex, is a composite. Alex is assembled from situations like yours and is not drawn from any real patient's record. Read it, decide whether it fits, and then decide how to raise it. The eligibility check, the intake and the choice would all be your partner's.
- The membership is cardiometabolic primary care: weight is one of several things measured and, where indicated, treated.
- Each quarterly panel covers ApoB, lipoprotein(a), hs-CRP, HbA1c and insulin markers, lipids, and thyroid and hormone panels.
- Medication is prescribed only when indicated, to your partner's chosen pharmacy at that pharmacy's price, with nothing taken on it.
- $299 a month and $598 at sign-up for the first two months; refunded in full if not accepted, non-refundable once accepted.
- Your partner's time goes on an intake, a quarterly lab draw, video visits and messages sent when they choose.
- It replaces the primary-care relationship and pairs with insurance; it does not replace insurance.
What you can see from across the kitchen
Alex is forty-four, with a career that runs on calendar invites and a household that runs on two of them. Over the last few years four clinicians have handled Alex's health, and they have never spoken to each other. The annual physical lasted about eight minutes, drew a basic panel, and ended with the word normal and a note to watch the cholesterol. An urgent-care visit for a sinus infection recorded a blood pressure reading that nobody followed up. A sleep consult ended with advice about screens. An orthopedist examined a knee and nothing else. Each did the job in front of them, and none was set up to see the whole picture.
You see it because you live with it. You remember which visit said what. You noticed that the tiredness, the weight and the broken sleep started drifting around the same time, and you have wondered whether they are connected. You have also read enough to know that the most visible change is the one most likely to land badly if you name it. So much of the advertising in this field leads with the scale that what you would be suggesting sounds, from the outside, like a diet with a prescription attached.
Then there is the answer you already expect: "I have a GP." It is a fair answer. A GP who sees Alex for eight minutes a year and draws a basic panel is doing what that visit was built to do. The open question is whether anyone is doing the rest. That means drawing the markers the basic panel leaves out, drawing them again three months later, and holding four clinicians' fragments in one record. If someone already is, you may not need us. If no one is, what is missing is a clinician with time, and raising it as a weight problem would miss the point as well as hurt.
Weight is the visible end of a longer chain
Cardiometabolic medicine starts from a plain observation. Weight, hormones, thyroid, blood sugar and insulin, lipids and inflammation behave as one system, and splitting them across separate providers is how they stay unsolved. The definitive guide to cardiometabolic optimization sets out the chain: insulin resistance drives weight gain, visceral fat disrupts hormones, disrupted hormones stall metabolism, and stalled metabolism feeds vascular inflammation. Read that sentence with Alex in mind. The weight, the afternoons and the cholesterol note may be three views of one process, or they may not. Nobody can tell from across the kitchen, and nobody can tell from a basic panel either.
When the physical ended with the word normal, it described the markers that were drawn and said nothing about the ones that were not. Normal is a population range, and Alex is one person.
When the physical ended with the word normal, it described the markers that were drawn and said nothing about the ones that were not.
That is the honest center of the answer to your question. The membership is built to find out what is going on before deciding what to do about it. A GLP-1 medication is one thing a clinician might prescribe once the picture is clear, for the patients it fits. Thyroid medication, hormone therapy and any FDA-approved medication the clinician judges indicated are others. For some patients the first plan contains no prescription at all. What your partner would be signing up for is the workup and the clinician who stays with it. Weight loss is an outcome some patients reach, and nobody honest can promise it.
Medicine is moving in this direction, and the movement shows up in dated facts. On the quarterly panel here, ApoB and insulin markers sit beside the LDL and glucose figures where many basic panels stop. In September 2026 the makers of Wegovy and Zepbound were publishing their own self-pay prices, so a branded medication now has a price anyone can look up. In February 2026 the labeling of hormone therapy changed, and the conversation a clinician has about it should change with it. And the $20,000-a-year concierge practice and the $99-a-month compounded app are no longer the only options. A flat-fee membership with a clinician who has time sits between them.
What we do not know is what Alex's panel will show, and we will not pretend to. That is the reason to draw it.
Alex's first three months, and what we would check
Before the first panel
Alex completes the eligibility check, then the intake, then checkout, where $598 is charged to cover the first two months. A clinician then reviews the intake, and not everyone is accepted. If the clinician cannot accept Alex into care, the $598 is refunded in full; once Alex is accepted, those first two months are non-refundable. The fee is generally eligible for HSA or FSA pre-tax dollars, which matters in a household that funds one.
Month one: the panel
The first cardiometabolic panel is the part most likely to surprise someone who expected a weight program. It covers ApoB, lipoprotein(a), hs-CRP, HbA1c and insulin markers, the lipid panel, and full thyroid and hormone panels. The clinician reads the cholesterol note from the physical beside ApoB, lipoprotein(a) and hs-CRP rather than on its own. The afternoons and the weight are read against the insulin markers and the thyroid. The sleep and the energy are read against the thyroid and hormone panels. None of those readings starts from the scale.
Every result goes into Alex's hands. A video visit follows with the clinician, who has read the panel alongside the history Alex brings, including whatever the four earlier clinicians wrote down.
Month two: the plan
In this composite, the conversation began with the lipid markers and the thyroid, and weight came up third. Another patient's panel would set a different order; the panel sets it, never the brochure.
If medication is indicated, it is prescribed to the pharmacy Alex chooses, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on it. The membership fee stays the same whatever is prescribed and at whatever dose, so the clinician has no financial reason to reach for one drug over another or a higher dose over a lower one. If a GLP-1 is ever indicated, it is branded and FDA-approved; no compounded GLP-1 is prescribed here under any circumstance. As published in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills and $349 a month after. The $199 price is an introductory offer for new patients through December 2026. As published the same month, LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. Whether a plan covers a medication is between Alex, the plan and the pharmacy. Prior authorization is the pharmacy's process. We never promise either.
The same unbundling covers thyroid medication and hormone therapy where indicated. The piece on hormone therapy at pharmacy cost shows how it works on that side of the panel.
A single panel is a snapshot; the quarterly re-draw, read by the same clinician, is what turns a decision about treatment from a guess into a feedback loop. Medication is prescribed only when it is clinically indicated, and the clinician decides.
Month three: what continues
The first two months end, and the membership continues month to month at $299. Alex can stop. If Alex stays, the next quarterly panel follows, read by the same clinician, so the month-one markers become a direction rather than a single reading. Four panels a year are included. Between panels Alex messages the care team when something comes up, and nobody has to rebuild the history at each visit.
How much of Alex's time it takes
Alex's time goes on the intake, a lab draw each quarter, video visits, and messages. Because the messaging is asynchronous, Alex sends them whenever it suits. We have not put a number of hours on it, because it varies from patient to patient and we would rather not guess.
Alex's first three months
A composite
| Month | What happens | What Alex does |
|---|---|---|
| Before month one | Eligibility check, intake, checkout at $598, clinician's review | Answers the questions; is accepted, or refunded in full if not |
| Month one | First cardiometabolic panel; results shared; video visit | One lab draw; one conversation |
| Month two | The plan, with medication to Alex's pharmacy only if indicated | Chooses the pharmacy; messages when needed |
| Month three | Month to month at $299 begins; next quarterly panel ahead | Stays or stops |
What it does not do
It pairs with insurance for catastrophic coverage and does not replace it, so the plan stays for the hospital. It does replace the primary-care relationship, and that is the honest answer to "I have a GP": Alex would move primary care here rather than add a fifth clinician to the four. It promises no weight loss, no remission and no cure. And the fee does not move with the prescription. Where revenue rises with each prescription, the incentive points toward prescribing. Here the answer can follow the panel, because we sell neither the drug nor the dose.
Before you raise it: one thing to do this week
Whatever you decide about us, there is something useful to do before the weekend. Ask your partner, without a pitch, whether they would pull up the results from their last physical; many practices post them in a patient portal. Look together for four names: ApoB, lipoprotein(a), fasting insulin and hs-CRP. If they are there, and someone reads them again every few months, your partner may already have what this membership offers, and you can stop here. If they are missing, you have a way into the conversation that has nothing to do with anyone's body: nobody has measured these, so would you want them measured?
That framing is also the accurate one. You would be pointing out that four clinicians have each seen a corner of the picture and nobody has seen the rest. If your partner says no, that answer is theirs to give, and the question about those four markers is still worth taking to their GP. If they say yes, the eligibility check is theirs to take. And if it works for them, the same kind of care is there for you.
Who this is not for
It is not for a partner who has not been asked. This is your partner's care, and a membership started as a surprise is a hard thing to use well. It is not for someone who wants a weight-loss prescription quickly and nothing else. We prescribe no compounded GLP-1, and a test-first membership will feel slow to anyone who wanted the prescription yesterday. It is not for someone who does not want to be tested, since the testing is the point. It is not for anyone hoping to drop their insurance. It is not for a patient whose GP already draws these markers quarterly and reads them over time. And it is for residents of the fifty states only.
Here is the offer in plain terms, so you can repeat it accurately. The membership is $299 a month. $598 is charged at sign-up for the first two months, and it is month to month after that. If the clinician cannot accept your partner into care, the $598 is refunded in full; once your partner is accepted, the first two months are non-refundable. Any medication follows the billing pharmacy's own refund policy. The fee buys four cardiometabolic panels a year, every result in your partner's hands, a clinician who stays, and messaging and video visits. When indicated, it also buys medication prescribed to the pharmacy your partner chooses at that pharmacy's price, with nothing taken on it. What it returns is the diagnosis an eight-minute visit never produced and markers followed over time instead of glimpsed once a year. It also ends the eight-minute visit and the work of stitching four clinicians together. It is different because it tests first and treats second, and sells neither the drug nor the dose. As for why now: you are already holding the picture that four clinicians have not seen, and you are holding it alone. The first panel would put it in front of someone whose job is to read it.
Related Reading
- Cardiometabolic Optimization: The Definitive Guide
- Bioidentical Hormone Therapy at Pharmacy Cost: The Real Numbers
References
- NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
- Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings